ProMIS Neurosciences Inc. (PMN) stock
PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.31+0.02 (+0.61%)
Close on Nov 16, 2026Market cap $29.68MP/E –Yield –
Earnings
ProMIS Neurosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 24, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.89
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of ProMIS Neurosciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 24, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026after the close | – | – | -$0.89 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 13, 2026after the close | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026before the open | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 25, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 12, 2025before the open | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024after the close | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Apr 1, 2024after the close | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023after the close | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023after the close | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023after the close | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 8, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022before the open | – | – | -$0.85 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022after the close | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
ProMIS Neurosciences has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When ProMIS Neurosciences puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases ProMIS Neurosciences filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Update
- Update
- Results
- Results
- News
- News
- Results
- Update
- Update
- Results
- News
- News
See a number that looks wrong?